Summary. To elucidate the diabetogenic effect of growth hormone on glucose metabolism the regulation of glucose transporter (GLUT) gene expression was examined in rat skeletal muscles. Female Wistar-Furth rats were implanted subcutaneously with growth-hormone-producing pituitary tumour (GH3) cells. Animals were killed 4 or 9 weeks after GH3 cell injection. Although body weight, serum growth hormone and insulin-like growth factor I levels were remarkably elevated during the 4-9 week Period, serum blood glucose levels were within normal range. Muscles were obtained from the quadriceps muscle, diaphragm and heart, respectively. Northern blot analysis and Western blot analysis were performed using specific cDNA probes and antibodies. During the 4-9 week period, the levels of muscle GLUT 1 and 4 mRNA (corrected by fl-actin mRNA level) in each muscle from the rats injected with turnout cells were not significantly different from those of control rats. Chronic elevation of growth hormone in these rats did not cause any change in GLUT 1 and 4 expression compared to the controls during the euglycaemic period. These results provide the first evidence that chronic growth hormone elevation itself does not affect a key gene of in vivo glucose metabolism.
Acromegaly is the clinical syndrome caused by excessive secretion of growth hormone (GH) from a functioning pituitary tumour [1] . One metabolic aspect of this syndrome is insulin resistance induced by GH, the mechanism of which is st~l unknown [2] . Clinically acromegalic patients may have glucose tolerance ranging from normal carbohydrate metabolism to diabetes mellitus of varying severity [3] [4] [5] [6] . There is, however, considerable confusion about the detailed aspects of GH action on carbohydrate metabolism, in part due to two different actions of GH; insulin-like and anti-insulin biological effects [7] . In experimental animals, acute injection of an excess amount of GH induced an insulin-like effect and chronic effects of GH are stimulation of insulin secretion and induction of insulin resistance [8] [9] [10] [11] [12] . In addition to these effects, an important role of GH is to regulate glucose production by the liver, glucose uptake in peripheral tissue (i. e., muscle and fat) and systemic amino acid turnover [2] . Studies of insulin receptor on circulating blood cells from patients with acromegaly [13] or on tissues from animals bearing GH-secreting tumours [14] provide insight into some of the mechanisms of insulin resistance in states of GH excess. The functional role of insulin receptor changes in the insulin resistance of acromegaly is, however, still unknown. Evidence that insulin resistance is secondary to post-receptor defects has been recently reported [15] . Another important function of insulin is its control of blood glucose concentrations by the stimulation of glucose uptake in specific insulin-sensitive tissues. Skeletal muscle makes up the largest tissue mass in the body and plays an important role in glucose homeostasis. Glucose transport is the first and probably rate-limiting step of muscle glucose util~ation [16] and the muscle glucose transporter (GLUT) has been identified as a potential site for the development of insulin resistance [17] . Although the different types of GLUT have been cloned and characterized as membrane-spanning proteins [18] [19] [20] [21] [22] [23] [24] [25] , studies of in vivo GH action on GLUT expression must be performed which will further our understanding of the mechanism of insulin resistance by chronic GH excess. Therefore, to elucidate the diabetogenic action of GH on muscle GLUT, we have examined the in vivo regulation of GLUT i and 4 during euglycaemia in various muscles: quadriceps muscle, diaphragm and heart. "p < 0.0t, b p < 0.001 VS respective control rats. n = 3-15, mean + SD
Materials and methods

Animals and experimental procedures
Female Wistar-Furth rats were used for the experiments. The rats were maintained in the Laboratory Animal Center for Biomedical Research, Nagasaki University School of Medicine andhoused in isolation in an environment of controlled light/darkness (lights on, 07.00-20.00 hours) and temperature (22 ± 1 °C) and permitted free access to food and water [26] . At the age of 4 weeks (100-120 g), 22 rat s were injected s. c. with 5.0 x 106 GH~ pituitary tumour cells [27] suspended in 0.1 ml Ham's F 10 medium containing penicillin (100 U/ml) and streptomycin (100 gg/ml) [28] . Twenty control rats were given an equal volume of vehicle Ham's F 10 only. Tumour-bearing and control rats were weighed each week, and tail venous blood samples (0.4 ml) were collected, centrifuged, and stored at -20°C. Glucose was measured in blood samples immediately. Four weeks after tumour cell injection, groups of rats (tumour-bearing and resp ective controls) were killed by decapitation, quadriceps, diaphragm and heart were aseptically removed, quickly frozen, and stored at -70 °C until extraction of RNA and preparation of membrane. Trunk blood was collected from the heart simultaneously for hormone RIA.
Radioimmunoassay
Rat GH (rGH) and insulin-like growth factor I (IGF-I) serum concentrations were determined in duplicate at three dilutions by RIAs using materials supplied by the National Hormone and Pituitary Agency, NIADDK (Bethesda, Md., USA). In the IGF-I RIA recombinant IGF-I (l~jisawa Pharmaceutical Co., Ltd., Osaka, Japan) was used as antigen and had a 50 % B/B0 (bound/background) to free ratio of 163 pg/tube. Insulin was measured in duplicate by a solid phase RIA (Insulin Beas II, Dinabot, "Ibkyo, Japan). Circulating blood glucose levels were measured by Glucostor (Miles-Sankyo Co. Ltd., Tokyo, Japan).
Northern gel analysis
Muscle tissues taken from the animals were subjected to total RNA extraction by acid-guanidinium thiocyanate phenol-chloroform method [29] . Total cellular RNA (25 gg) were denatured by incubation at 65 °C with 50 % formamide as described previously [30] . After RNA transfer from the gel to Hybond N nylon membrane paper, the paper was prehybridized and hybridized with 106 cpm [32p]-labelled GLUT cDNA probe, or fl-actin cDNA before exposure to X-ray film for autoradiography as described previously [31] . The rehybridization was performed after incubating in 0.1 x SSC (1 x SSC; 0.15 mol/1 NaC1 and 0.015 tool/1 sodium citrate,pH 7.0) and 0.1% sodium dodecylsulphate(SDS) at95-100°Cfor30 min.TheGLUT lcDNAprobe containing a 2.4 kilobase (kb) size DNA was provided by Dr. J. S. Flier (The Whitehead Institute of Biomedical Research, MIT, Boston, Mass., USA). The pGEM was used for propagation of pGT25Lplas-mid (Barn-HI cloning site) [32] . The GLUT 4 cDNA probe containing 800 basepair size cDNA and is a Hind III/EcoRI fragment of pGEM-3Zf (-) was provided by Dr. D. E. James (Washington University, St. Louis, Mo., USA) [33] . The fl-actin probe was provided by Dr. L. Kedes (Stanford University, Palo Alto, Calif., USA) [34] . The probes used in this study were labelled with c~-[3zp]-dCTP by multiprime DNA-labelling systems (Amersham, Tokyo, Japan) to a specific activity of approximately 5-10 x 108 cpm/gg DNA.
Quantitation of GLUT 1 and 4 mRNA
The specificity of GLUT 1 and 4 mRNA was confirmed by the positions of autoradiographic bands, 2.9 kb and 2.8 kb, respectively. To compare the density of each band, a Bioimage Analyser (BAS-2000; Fuji Film, Tokyo, Japan) was used to accurately measure the density of GLUT and fl-actin mRNA, respectively.
Preparation of membranes
Total membrane fractions from rat tissues were prepared as previously described with some modifications [35] . Muscles were excised and homogenized by a Potytron homogenizer (Kinematica, Littau, Switzerland) in 10mmol/l Tris-HC1, I mmolll EDTA, 250 mmoi/1 sucrose, pH 7.4 containing 1 mmol/1 phenylmethylsulphonyl fluoride. The homogenates were centrifuged at 900 x g for 10 min at 4 °C to sediment the fraction containing mainly the nuclei and mitochondria. The resulting supernatant was centrifuged at 146 x 103g for 75 min at 4 °C to yield a pellet designated as the total membrane fraction in this study.
Western blot analysis
Membrane fractions (50 gg protein) prepared as described above were suspended in 1% SDS and 2.5% mercaptoethanol, 12.5% glycerol and 50 mmol/1 dithiothreitol in 10 mmol/1Tris-HC1 (pH 6.8) and subjected to SDS-polyacrylamide (10 %) gel electrophoresis as described previously [36] . Electrophoretie transfer to nitrocellulose membrane (ADVANTEC, Tokyo, Japan) was carried out. The nitrocellulose filters were incubated for I h at room temperature in phosphate-buffered saline (0.18 mmol/1 NaC1, 2.68 mmot/1 KC1, 4.02 mmol/1NazHPO4,1.76 mmolfl KHzPO4) (PBS), pH 7. Weeks after tumour-bearing
Quantitative analysis by Bioimage Analyser of GLUT mRNA levels after 4 and 9 weeks. The same amount of total RNA (25 gg/lane) was loaded and the GLUT-1 or 4 mRNA/fl-actin mRNA in each muscle was compared as an arbitrary unit [GH3 (GLUT mRNA/flactin mRNA)]/[Control (GLUT mRNA/fl-actin mRNA)]. A: GLUT 1 mRNA levels in each muscle after 4 and 9 weeks, n = 3-10; B: GLUT 4 mRNA levels in each muscle after 4 and 9 weeks, n = 3-8. There were no significant differences between the two time points for GLUT expression in the muscles studied ham, Mass., USA) or a 1:40 dilution of mouse anti-rat glucose transporter (insulin-regulated) monoclonat antibody (IF-8) (Genzyme Corp., Cambridge, Mass., USA), in the same solution with 1% Triton X-100 for 1 h at 37 °C. The filters were washed for 30 min three times in PBS with t % Triton X-100 at room temperature, and incubated with mSI-labelled protein A (0.2 gCi/ml) for 1 h at 37 °C. The papers were washed two times in PBS with 1% Triton X-100 and autoradiographed for 1M days. These papers were analysed by Bioimage Analyser.
Statistical analysis
All data are presented as the mean +_ SD. Statistical analysis was performed by the non-parametric tests (unpaired t-test, Wilcoxon). P values less than 0.01 were considered to indicate a statistically significant difference.
Results
F o u r weeks after s u s p e n d e d t u m o u r cells were injected, the t u m o u r -b e a r i n g rats b e g a n increasing in b o d y weight c o m p a r e d to controls. B y the end of 9 weeks, the tumourb e a r i n g rats were almost two times the weight of controls (341 + 33 g vs 196 + 3 g; p < 0.001). Circulating G H and I G F -I levels were e l e v a t e d in t u m o u r -b e a r i n g rats as shown in Table 1 . D u r i n g the 4 -9 w e e k period, however, the serum levels of glucose were not different b e t w e e n the two groups, although a l r e a d y 4 weeks after t u m o u r imp l a n t a t i o n circulating insulin levels were e l e v a t e d in GH3 t u m o u r b e a r i n g rats (48.99 + 13.65 vs 22.16_+ 1,97, p < 0.01). The R N A of t u m o u r -b e a r i n g and respective controls was a n a l y s e d by the N o r t h e r n blot t e c h n i q u e Weeks after tumou r-bearing There were statistically significant differences between time points for GLUT expression in all of the muscles studied quantitate the G L U T I and 4 m R N A levels, we also analysed three to ten rats at each time point using the quantitative bioimage analysing system. The G L U T 1 or 4 mRNA/fl-actin m R N A in each muscle obtained from tumour-bearing rats at the indicated time point was compared with those from respective controls. The abundance of G L U T 1 and 4 m R N A at each muscle was not altered during the 4-9 week period (Fig. 2) . The amount of G L U T 1 and 4 protein in a crude membrane preparation of each skeletal muscle was quantitated by Western blotting with two independent specific antibodies against rat G L U T 1 and 4, respectively. The polyclonal antibody against G L U T 1 could detect a single band of 50 kDa in quadriceps, diaphragm and heart muscle, respectively. The relative abundance of G L U T 1 protein in tumour-bearing rat was compared with that in respective controls after 4 and 9 weeks of treatment. There was no change observed between them (Fig. 3A) . The immunoblots were also performed with an anti-G L U T 4 antibody (1F8). The size and amount of G L U T 4 protein in tumour-bearing rats did not change compared to that of the respective controls after 4--9 weeks of treatment (Fig.3B) . To further confirm the stability of G L U T 1 and 4 protein levels, the three different muscles were subjected to Western blot analysis using tumourbearing and respective control rats (4 and 9 weeks). The results of quantitative bioimage analysis are summarized in Figure 4 . At 4 and 9 weeks after injecting turnout cells, the abundance of G L U T 1 and 4 protein in each muscle was not altered.
Discussion
The mechanisms responsible for the diabetogenic action of G H on insulin-sensitive tissues are poorly understood although G H has been reported to antagonize the effects of insulin on glucose metabolism. Our experimental data demonstrate that chronic G H elevation itself did not alter the expression levels of G L U T 1 and G L U T 4 in rat skeletal muscles. Despite the alteration of glucose uptake by G H reported in the cultured cells [37, 38] , elevated circulating G H and IGF-I concentrations did not induce abnormalities in glucose regulation during in vivo experimental periods studied [39] . By 4 weeks serum G H concentrations were only doubled as compared to 9 weeks when G H concentrations were 40-to 60-fold greater than control rats. Even if the rats used in our study, as in the study of Bates et al. [40] were neither obese nor diabetic, there does not appear to be any altered expression of G L U T in skeletal muscles. Differential expression and regulation of GLUT 1 and 4 in different muscles have been reported [41, 42] . In humans, there are no changes in GLUT 1 or GLUT 4 mRNA or protein levels in skeletal muscle from obese subjects or obese Type 2 diabetic (non-insulin-dependent) subjects compared to controls [43, 44] . As spontaneous obese mice (ob/ob) have been a useful model to study the mechanism of insulin resistance and diabetes susceptibility [45] , their GLUT gene expression has been studied. However, the marked defect in glucose utilization of ob/ob mice is not due to a decrease of GLUT 4 levels [46] . Even among obese diabetic subjects, it is not known whether the expression of GLUT i or GLUT 4 in skeletal muscles is altered [43, 44, 47] . Tai et al. [48] have reported, using cultured adipose cells, that GH decreases GLUT 1 protein and mRNA levels and that levels of GLUT 4 are not regulated by chronic GH treatment. The amount of adipose tissue from GH tumour bearing rats was too small to be able to allow analysis of GLUT gene expression. In contrast insulin stimulates both GLUT 1 and GLUT 4 mRNA in rat L6 skeletal muscle cells [48, 49] . However, no change in GLUT 1 and GLUT 4 expression was demonstrated although the circulating insulin level was known to be significantly elevated in these tumour-bearing animals [50] . Furthermore the significance of developmental regulation of GLUT expression has been reported in various tissues [51] . Taken together with these observations, elevated insulin and IGF-I levels did not affect the expression of GLUT i and 4 genes in our in vivo models during the experimental periods, suggesting that the interaction among these hormones on GLUT gene expression counteract each other. Alternatively, insulin resistance in these rats may occur independently of the interaction between GH and GLUT gene expression. The change in insulin-regulatable GLLW 4 gene expression was not apparent probably, in part, because of the small changes of circulating insulin levels under these GHs tumour-beafing conditions. Our preliminary results, furthermore, demonstrated that over 18 weeks the tumour-bearing rats induced the elevation of circulating glucose levels. Rats, 20 weeks after GH3 cell injection showed a decreased expression of GLUT gene. However, diabetic rats which have large GH producing tumours over a long period are not suitable for analysing effects on GLUT gene expression. This is due to the deteriorating general condition of the rat and other multifactorial influences: i.e. overproduction of various cytokines and secondary cachexia. Alternatively, hyperglycaemia itself induced by GH excess might interfere with muscle GLUT gene expression. The potential alterations in GLUT protein distribution or function could be involved in the mechanisms for the diabetogenic effects of GH in the same way as for insulin resistance in human Type i (insulin-dependent) diabetes [52] . Finally using these animal models the interaction of other diabetogenic factors and muscle GLUT gene regulation can be studied.
